UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 160 filers reported holding UNIQURE NV in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $239,560 | -46.9% | 20,904 | -6.8% | 0.00% | -50.0% |
| Q1 2023 | $451,519 | -63.1% | 22,419 | -58.5% | 0.01% | -25.0% |
| Q4 2022 | $1,224,362 | +90.7% | 54,008 | +57.8% | 0.01% | -11.1% |
| Q3 2022 | $642,000 | +11.3% | 34,229 | +10.6% | 0.01% | +12.5% |
| Q2 2022 | $577,000 | -3.7% | 30,939 | -6.7% | 0.01% | +14.3% |
| Q1 2022 | $599,000 | -13.7% | 33,144 | -0.9% | 0.01% | 0.0% |
| Q4 2021 | $694,000 | – | 33,459 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |